다국적 제약회사 신약개발 국제자문위원 연구책임자로 정부 과제 수행 (보건복지부, 교육과학부, 지식경제부) 보건복지부 질병관리본부 간염분과 자문위원 (2013-현재) 식품의약품안전평가원 의약품 심사자문단 (2014-현재) 식품의약품안전처 중앙약사심의위원회 전문가 (2014-현재) 한국의약품안전관리원 자문위원 (2017-현재) 한국보건의료연구원 신의료기술평가사업 자문위원 (2013-현재) 한국보건의료연구원 연구기획 자문위원 (2020년-현재) EBS [명의] 선정 (2017), 월간조선 [신(新)명의] 선정(2017) Marquis Who's Who (세계 상위 3% 전문인) 등재 (2018)
논문
2021 Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients JOURNAL OF KOREAN MEDICAL SCIENCE
2021 Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B CLINICAL AND MOLECULAR HEPATOLOGY
2021 Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B HEPATOLOGY RESEARCH
2021 Association Between Curative Treatment after Transarterial Radioembolization and Better Survival Outcomes in Patients with Hepatocellular Carcinoma CANCER INVESTIGATION
2021 Cost-Effectiveness Analysis of Antiviral Therapy for Untreated Minimally Active Chronic Hepatitis B to Prevent Liver Disease Progression CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY
2021 Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization CURRENT ONCOLOGY
2021 Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study CLINICAL AND MOLECULAR HEPATOLOGY
2021 Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY
2021 Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy GUT AND LIVER
2021 Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma YONSEI MEDICAL JOURNAL
2021 Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir JOURNAL OF VIRAL HEPATITIS
2021 Hepatitis B Core-Related Antigen to Indicate High Viral Load: Systematic Review and Meta-Analysis of 10,397 Individual Participants CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2021 Evolution of liver fibrosis and steatosis markers in patients with type 2 diabetes after metformin treatment for 2 years JOURNAL OF DIABETES AND ITS COMPLICATIONS
2020 A multi-centre study of trends in hepatitis B virus-related hepatocellular carcinoma risk over time during long-term entecavir therapy JOURNAL OF VIRAL HEPATITIS
2020 Efficacy of Lenvervimab, a Recombinant Human Immunoglobulin, in Treatment of Chronic Hepatitis B Virus Infection CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2020 Hepatitis B Virus Cure: Targets and Future Therapies INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2020 Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion JOURNAL OF HEPATOCELLULAR CARCINOMA
2020 Combined use of rosuvastatin and ezetimibe improves hepatic steatosis in patients with dyslipidemia EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2020 Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study GUT
2020 Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study KOREAN JOURNAL OF INTERNAL MEDICINE
2020 The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization GUT AND LIVER
2020 Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals CANCERS
2020 Association between liver fibrosis and appendicular skeletal muscle mass during antiviral therapy in chronic hepatitis B DIGESTIVE AND LIVER DISEASE
2020 High body mass index hinders fibrosis improvement in patients receiving long-term tenofovir therapy in hepatitis B virus-related cirrhosis JOURNAL OF VIRAL HEPATITIS
2020 Advanced Liver Fibrosis Predicts Unfavorable Long-Term Prognosis in First-Ever Ischemic Stroke or Transient Ischemic Attack CEREBROVASCULAR DISEASES
2020 Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study) HEPATOLOGY INTERNATIONAL
2020 Factors associated with improvement in MELD score after antiviral treatment in patients with chronic hepatitis B JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2020 Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus GUT AND LIVER
2020 Entecavir and tenofovir on renal function in patients with hepatitis B virus-related hepatocellular carcinoma JOURNAL OF VIRAL HEPATITIS
2020 Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation CANCERS
2020 Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement LANCET GASTROENTEROLOGY & HEPATOLOGY
2020 Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial AMERICAN JOURNAL OF GASTROENTEROLOGY
2020 A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement JOURNAL OF HEPATOLOGY
2020 RNA Interference Therapy With ARC-520 Results in Prolonged Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis B Infection HEPATOLOGY
2020 IFNL3-adjuvanted HCV DNA vaccine reduces regulatory T cell frequency and increases virus-specific T cell responses JOURNAL OF HEPATOLOGY
2020 An optimized hepatocellular carcinoma prediction model for chronic hepatitis B with well-controlled viremia LIVER INTERNATIONAL
2020 Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response CLINICAL AND MOLECULAR HEPATOLOGY
2020 Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase ALIMENTARY PHARMACOLOGY & THERAPEUTICS
2020 Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study GUT AND LIVER
2020 How do genetic variants affect our interpretation of non-invasive tests for non-alcoholic fatty liver disease? JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2020 Establishment and Validation of a Risk Prediction Model in Patients With Hepatocellular Carcinoma Treated With Transarterial Radioembolization EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2020 Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study LANCET GASTROENTEROLOGY & HEPATOLOGY
2020 Impact of Interferon-Based Treatment on Quality of Life and Work-Related Productivity of Korean Patients with Chronic Hepatitis C GUT AND LIVER
2020 Influence of Besifovir Dipivoxil Maleate Combined With L-Carnitine on Hepatic Steatosis in Patients With Chronic Hepatitis B JOURNAL OF KOREAN MEDICAL SCIENCE
2020 Efficacy and Safety of Liver-Directed Concurrent Chemoradiotherapy and Sequential Sorafenib for Advanced Hepatocellular Carcinoma: A Prospective Phase 2 Trial INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2020 A Tool to Measure the Impact of Inaction Toward Elimination of Hepatitis C: A Case Study in Korea PLOS ONE
2020 Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk AMERICAN JOURNAL OF GASTROENTEROLOGY
2020 Design and Validation of Risk Prediction Model for Hepatocellular Carcinoma Development After Sustained Virological Response in Patients With Chronic Hepatitis C EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2020 HKR3 Regulates Cell Cycle Through the Inhibition of hTERT in Hepatocellular Carcinoma Cell Lines JOURNAL OF CANCER
2020 A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea CLINICAL AND MOLECULAR HEPATOLOGY